BIBF 1120
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Boehringer Ingelheim
Overview
BIBF 1120 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
BIBF 1120 clinical trials
Explore related
Medical disclaimer. This page summarizes research about BIBF 1120 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.